Results

Total Results: 1,027 records

Showing results for "drug".

81. Draft Recommendation: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/prevention-human-immunodeficiency-virus-hiv-infection-prep
    December 13, 2022 - of Risk for HIV Acquisition HIV infection is primarily acquired via sexual activity or injection drug … It is important that clinicians routinely take a sexual and injection drug use history for all their … Food and Drug Administration (FDA) for use as PrEP. … It is important that clinicians routinely take a sexual and injection drug use history for all their … Research is needed on different drug regimens and dosing strategies for PrEP.

82. ahrq29a - Screening for Hepatitis C in Adults - Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/aSLgQ3VeNEmowQmpvPk_Xe
    March 01, 2004 - before 1990 will continue to decline, and HCV infection will be associated mainly with intravenous drug … for HCV infection (adjusted odds ratio [OR], 23), followed by hemodialysis, sex with an intravenous drug … user, a history of blood transfusion, and male gender.8 In cross-sectional studies of intravenous drug … Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. … Hepatitis C virus in intravenous drug users. Med J Aust. 1990; 153:(5):274–276. 14.

83. Alex H. Krist, M.D., M.P.H. | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/alex-h-krist-md-mph
    March 01, 2020 - participated in many expert panels, and served on several national committees, including the Gastrointestinal Drug … Food and Drug Administration, the research committee for Family Medicine for America’s Health, the health

84. Announcements | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=9
    July 30, 2020 - and Glaucoma in Adults 2020-06-11 Final Recommendation Statement: Screening for Unhealthy Drug … 2020-06-02 Final Recommendation Statement: Primary Care–Based Interventions to Prevent Illicit Drug

85. Preexposure Prophylaxis to Prevent Acquisition of HIV: Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ndk2qMLMrpq_DLV5ddEQFd
    August 22, 2023 - Assessment of Risk for HIV Acquisition HIV is primarily acquired via sexual activity or injection drug … It is important that clinicians routinely take a sexual and injection drug use history for all their … • Routinely take a sexual and injection drug use history for all patients. … Effective formulations of PrEP with current US Food and Drug Administration approval include: • Oral … • Research is needed on different drug regimens and dosing strat- egies for PrEP.

86. Preexposure Prophylaxis for the Prevention of HIV Infection: Evidence Report and Systematic Review for the US Preventive Services Task Force (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
    June 11, 2019 - , the risk behaviors examined in these trials varied (recep- tive anal intercourse, condomless sex, drug … Placebo (n = 1209) PWID: Injection drug use in the previous 12 mo A vs B: Age 20-29 y: 43% vs 43% Age … 33 y Women: 50% vs 46% vs 67% vs 42% Race: NR 98 (MEMS) Good IAVI; Gilead Sciences (provided study drug … Center for Drug Evaluation and Research (CDER). … Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or

87. Draft Research Plan: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/prevention-human-immunodeficiency-virus-hiv-infection-prep
    November 04, 2021 - renal dysfunction, adverse effects on bone, pregnancy-related outcomes, infection with antiretroviral drug-resistant … What is the risk of infection with antiretroviral drug–resistant HIV in persons treated with PrEP, and … what is the effect of infection with PrEP-related, antiretroviral drug–resistant HIV on treatment outcomes

88. Archived: Osteoporosis: Screening 2011 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-2011
    January 15, 2011 - Clinicians should provide education about how to minimize drug side effects. … Harms of drug therapies for osteoporosis depend on the specific medication used. … Clinicians should provide patient education on how to use drug therapies to minimize adverse effects. … Drug therapies for osteoporosis can be for primary prevention (prevention of an osteoporotic fracture … Drug therapies include bisphosphonates, parathyroid hormone, raloxifene, estrogen, and calcitonin.

89. Archived: Human Immunodeficiency Virus (HIV) Infection: Screening, 1996 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-1996
    January 01, 1996 - Among drug users in treatment, drug use and needle sharing decline after HIV counseling and testing but … Updated estimates of the impact and cost of HIV prevention in injection drug users. … High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. … Syringe and needle exchange as HIV/AIDS prevention for injection drug users. … Drug use and sexual behaviors among sex partners of injecting drug users—United States 1988-1990.

90. Archived: Evidence Summary: Blood Pressure in Children and Adolescents (Hypertension): Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary16/blood-pressure-in-children-and-adolescents-hypertension-screening-october-2013
    February 15, 2013 - Drug Interventions All seven included trials of drug interventions examined different drugs 53-59 … Drug Interventions Twelve trials reported adverse events with drug therapy ( Appendix 6 ) 53-59 , … Two studies pooled adverse event data from selected drug trials submitted to the Food and Drug Administration … For those with primary hypertension, interventions include drug, lifestyle, and combination drug and … 14 RCTs (poor) Longest drug study duration was only 4 wk.

91. Screening for Hypertension in Children and Adolescents (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Aqm6uW6_HrTRVJ-EVCVaRV
    March 01, 2013 - Seven studies reported that drug interventions effectively lowered blood pressure in adolescents over … What is the effectiveness of drug, non- drug, and combination interventions PEDIATRICS Volume 131, … compared active drug (in differ­ ent doses) to placebo, with follow-up of only 4 weeks. … Also, comparison among studies was difficult because of varying drug dosages. … Drug Interventions Twelve trials reported adverse events with drug therapy (Appendix 6).53–59,67–71

92. Archived: Hepatitis C: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening-2013
    June 15, 2013 - Risk Assessment The most important risk factor for HCV infection is past or current injection drug … before 1992, long-term hemodialysis, being born to an HCV-infected mother, incarceration, intranasal drug … Screening Interval Persons with continued risk for HCV infection (such as injection drug users … use, sex with an injection drug user, and receipt of blood transfusion before 1992. … Food and Drug Administration drug approval.

93. Screening for Hepatitis C Virus Infection in Adolescents and Adults: Clinician Summary of USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/NLdjpD96K5VS8o3CSU_s2X
    March 01, 2020 - and older than 79 years who are at high risk for infection (eg, those with past or current injection drug … Periodically screen persons with continued risk for HCV infection (eg, persons with past or current injection drug

94. Final Research Plan: Prevention of Acquisition of HIV: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    January 13, 2022 - renal dysfunction, adverse effects on bone, pregnancy-related outcomes, infection with antiretroviral drug-resistant … What is the risk of infection with antiretroviral drug–resistant HIV in persons using PrEP, and what … is the effect of infection with PrEP-related, antiretroviral drug–resistant HIV on treatment outcomes

95. Let’s Talk About It: Preventing HIV with PrEP (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/hiv-prep-prevention-discussion-guide.pdf
    August 22, 2023 - Preventing HIV with PrEP Let’s Talk About It For Patients Preventing HIV with PrEP Talking about sex, drug … • You share needles or other drug injection equipment. … limitations, healthcare professionals should routinely take a sexual history and ask about any injection drug

96. Clinical Summary: Screening for Osteoporosis to Prevent Fractures (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ShJmbuCXvmGjpnvyyR9PH_
    June 20, 2018 - Treatments The US Food and Drug Administration has approved multiple drug therapies to reduce osteoporotic

97. Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/pskqLZMFcHjhtEF75uG4AP
    January 01, 2012 - tests in predicting fractures, the harms of screening for osteoporosis, and the benefits and harms of drug … Because of the lack of relevant studies, the USPSTF found inadequate evidence that drug therapies reduce … Harms of drug therapies for osteoporosis depend on the specific med- ication used. … Cli- nicians should educate patients on how to use drug thera- pies to minimize adverse effects. … Drug therapies include bisphosphonates, parathyroid hormone, raloxifene, estrogen, and calcitonin.

98. Archived: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening-may-2014
    June 18, 2014 - sub-Saharan Africa and southeast and central Asia HIV-positive persons Injection drug … Food and Drug Administration–approved hepatitis B surface antigen (HBsAg) test followed by a licensed … alanine aminotransferase levels; the presence of HBeAg, coinfection, and cirrhosis; and the choice of drug … Food and Drug Administration and are generally not used as first-line treatment because tolerability, … High prevalence of occult hepatitis B in Baltimore injection drug users.

99. Archived: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
    June 18, 2014 - sub-Saharan Africa and southeast and central Asia HIV-positive persons Injection drug … Food and Drug Administration–approved hepatitis B surface antigen (HBsAg) test followed by a licensed … alanine aminotransferase levels; the presence of HBeAg, coinfection, and cirrhosis; and the choice of drug … Food and Drug Administration and are generally not used as first-line treatment because tolerability, … High prevalence of occult hepatitis B in Baltimore injection drug users.

100. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
     March 15, 2007 - Nonsteroidal Anti-inflammatory Drug (NSAID) Chemoprevention of Colonic Adenomas: Included Randomized, … Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. … Pharmacoepidemiol Drug Saf 1998;7:99-106. [PMID: 15073733] 50. … Food and Drug Administration. … Arthritis & Drug Safety and Risk Management Advisory Committee Briefing Package.